Become a Distributor

Remibrutinib

Impurities - Remibrutinib is an oral Bruton's tyrosine kinase (BTK) inhibitor developed for the treatment of chronic spontaneous urticaria and other immune-mediated inflammatory conditions. Reference standards of Remibrutinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => tert-Butyl (2-((4,6-dichloropyrimidin-5-yl)oxy)ethyl)(methyl)carbamate
    [catalogue_number] => PA 18 1821004
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 322.19
    [form] => C12H17Cl2N3O3
    [cas] => 2762738-16-7
    [pslug] => 2762738-16-7-tert-butyl-2-4-6-dichloropyrimidin-5-yl-oxy-ethyl-methyl-carbamate-pa181821004
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

tert-Butyl (2-((4,6-dichloropyrimidin-5-yl)oxy)ethyl)(methyl)carbamate

Catalogue No.:PA 18 1821004
CAS :
2762738-16-7
Molecular Formula : C₁₂H₁₇Cl₂N₃O₃
Molecular Weight : 322.19

Enquire

Details

stdClass Object
(
    [pname] => tert-Butyl (2-((4,6-diaminopyrimidin-5-yl)oxy)ethyl)(methyl)carbamate
    [catalogue_number] => PA 18 1821005
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 283.33
    [form] => C12H21N5O3
    [cas] => NA
    [pslug] => tert-butyl-2-4-6-diaminopyrimidin-5-yl-oxy-ethyl-methyl-carbamate-pa181821005
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)